The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...
With this expanded portfolio, our users can now choose the most appropriate coil for each specific patient, prioritizing comfort, treatment precision, and outcomes.” — Kerry Rome, SVP MagVenture, Inc.
This life-changing Health Canada-approved technology directly targets the brain circuits involved in OCD—without the side effects of medication. Patients tell us they feel like they’re finally getting ...
KANSAS CITY, Mo. — You've probably heard of obsessive compulsive disorder before. But did you realize you can treat OCD, without drugs, with TMS Therapy? Sunrise Psychiatry is offering a cutting-edge ...
Expert behavioral medicine specialists and neurologists at the WVU Rockefeller Neuroscience Institute (RNI) offer an alternative and complementary treatment option for adult patients who have major ...
Munich, Germany; Atlanta, Georgia - September 10, 2025 – neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health and performance, today announced it has ...
BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BRSYF) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Our understanding of mental illness—and wellness, for that matter—is still in its infancy, even after more than a century of inquiry. Why is that? Partly because understanding the brain has required ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback